¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Facial Neoplasms"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • facial palsy
    ¾ó±¼¸¶ºñ, ¾È¸é¸¶ºñ
  • facial paralysis
    ¾ó±¼¸¶ºñ
  • facial reflex
    ¾ó±¼¹Ý»ç, ¾È¸é±Ù¹Ý»ç
  • facial restoration
    ¾ó±¼º¹¿ø
  • facial schwannoma
    ¾ó±¼½Å°æÁýÁ¾
  • facial skeleton
    ¾ó±¼»À´ë, ¾È¸é°ñ°Ý
  • facial spasm
    ¾ó±¼¿¬Ãà
  • facial vein
    ¾ó±¼Á¤¸Æ, ¾È¸éÁ¤¸Æ
  • idiopathic facial paralysis
    Ư¹ß¾ó±¼¸¶ºñ
  • oral-facial-digital syndrome
    ÀÔ¾ó±¼¼Õ°¡¶ôÁõÈıº, ±¸°­¾È¸é¼öÁ·ÁöÁõÈıº
  • spasmodic facial neuralgia
    ¿¬Ãà¾ó±¼½Å°æÅë, ¿¬Ãà¾È¸é½Å°æÅë
  • spinal accessory-facial nerve crossover
    ô¼ö´õºÎ¾ó±¼½Å°æ±³Â÷(¼ú), ô¼öºÎ¾È¸é½Å°æ±³Â÷(¼ú)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • facial nucleus
    ¾ó±¼½Å°æÇÙ
  • facial palsy
    ¾ó±¼½Å°æ¸¶ºñ
  • facial paralysis
    ¾ó±¼¸¶ºñ
  • facial reconstruction
    ¾ó±¼Àç°Ç(¼ú)
  • facial reflex
    ¾ó±¼¹Ý»ç, ¾È¸é±Ù¹Ý»ç
  • facial restoration
    ¾ó±¼º¹¿ø
  • facial schwannoma
    ¾ó±¼½Å°æÁýÁ¾
  • facial skeleton
    ¾ó±¼»À´ë
  • facial spasm
    ¾ó±¼¿¬Ãà
  • facial bone contouring surgery
    ¾ó±¼»ÀÀ±°û±³Á¤¼ú
  • female facial melanosis
    ¿©¼º¾ó±¼Èæ»öÁõ
  • idiopathic facial paralysis
    Ư¹ß¾ó±¼¸¶ºñ
  • spasmodic facial neuralgia
    ¿¬Ãà¾ó±¼½Å°æÅë
  • oral-facial-digital syndrome
    ÀÔ¾ó±¼¼Õ°¡¶ôÁõÈıº, ±¸°­¾È¸é¼öÁ·ÁöÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • postoperative facial palsy
    ¼úÈľȸé½Å°æ¸¶ºñ(âúý­äÔØüãêÌèØ«Ýö)
  • progressive facial paralysis
    ÁøÇà(¼º) ¾È¸é¸¶ºñ
  • progressive unilateral facial atrophy
    ÁøÇ༺ Æí¾È¸éÀ§Ãà(òäú¼àõø¸äÔØüê×õê ).
  • progressive unilateral facial atrophy
    ÁøÇ༺ Æí¾È¸éÀ§Ãà(òäú¼àõ ø¸äÔØüê×õê )
  • prominence of facial canal
    ¾ó±¼½Å°æ°üÀ¶±â
  • prominence of facial canal ³ª prominentia canalis facialis
    ¾ó±¼½Å°æ °üÀ¶±â, ¾È¸é½Å°æ°üÀ¶±â(äÔØüãêÌèηëØÑÃ).
  • prominence of facial canal ³ª prominentia canalis facialis
    ¾ó°óº·w °üÀ¶±â, ¾È¸é½Å°æ°üÀ¶±â(äÔØüãêÌèηëØÑÃ).
  • prosopoplegia =facial paralysis
    ¾È¸é¸¶ºñ(äÔØüØ«Ýö)
  • prosopoplegia [=facial paralysis]
    ¾È¸é¸¶ºñ
  • proximal facial nerve
    ±ÙÀ§¾È¸é½Å°æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • facial atrophy
    ¾È¸éÀ§Ãà
  • facial atypical necrobiosis lipoidica
    ¾È¸é ºÎÁ¤Çü À¯Áö¹æ¼º »ý±«»ç
  • facial canal
    ¾ó±¼½Å°æ°ü.
  • facial canal
    ¾ó±¼½Å°æ°ü
  • facial canal
    ¾È¸é½Å°æ°ü
  • facial cleft
    ¾È(¸é)¿­(äÔØüæñ).
  • facial colliculus
    ¾ó±¼½Å°æµÐ´ö
  • facial coloboma
    ¾È¸é(°á)·Ä(¡­°á¿­).
  • facial cranium
    ¾È¸éµÎ°³(¡­ÔéËÏ).
  • facial cranium viscerocranium
    ¾ó±¼¸Ó¸®»À
  • facial defect
    ¾ó±¼°áÇÔ
  • facial diplegia
    ¾È¸é¾çÃø¸¶ºñ.
  • facial edema
    ¾È¸éºÎÁ¾.
  • facial fissure
    ¾È¿­(¾È¿­), ¾È¸éÆÄ¿­(¡­ÆÄ¿­).
  • facial granuloma
    ¾È¸é À°¾ÆÁ¾
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Area of facial nerve
    ¾ó±¼½Å°æ±¸¿ª
    [¿¾ ¿ë¾î] ¾È¸é½Å°æ¾ß
  • Facial colliculus
    ¾ó±¼½Å°æµÐ´ö
    [¿¾ ¿ë¾î] ¾È¸é½Å°æ±¸
  • Internal genu of facial nerve
    ¾ó±¼½Å°æ¼Ó¹«¸­
    [¿¾ ¿ë¾î] ¾È¸é½Å°æ³»½½
  • Facial nucleus
    ¾ó±¼½Å°æÇÙ
    [¿¾ ¿ë¾î] ¾È¸é½Å°æÇÙ
  • Facial vein
    ¾ó±¼Á¤¸Æ
    [¿¾ ¿ë¾î] ¾È¸éÁ¤¸Æ
  • Hiatus of facial canal
    Å«¹ÙÀ§½Å°æ°üÆ´»õ
    [¿¾ ¿ë¾î] ´ëÃßü½Å°æ°ü¿­°ø
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AIPFP acute idiopathic peripheral facial nerve palsy
COFS cerebro-oculo-facial-skeletal [syndrome]
FFDD focal facial dermal dysplasia
FH facial hemihyperplasia; familial hypercholesterolemia; family history; fasting hyperbilirubinemia; f...
ICF immunodeficiency-centromeric instability-facial anomalies [syndrome]; indirect centrifugal flotation...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
VCFS Velo-Cardio-Facial Syndrome
FN facial nerve
FN facial nucleus
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • facial arthromyalgia
    ¾È¸é °üÀý±ÙÅë
  • facial atrophy
    ¾È¸é À§Ãà
  • facial augmentation implant prosthesis
    ¾È¸é Áõ´ë ÀÓÇöõÆ® º¸Ã¶¹°
  • facial bone
    ¾ó±¼ »À, ¾È¸é °ñ
  • facial cellulitis
    ¾È¸é ºÀ¿ÍÁ÷¿°
  • facial colliculus
    ¾ó±¼ ½Å°æ µÐ´ö
  • facial cranial nerve
    ¾È¸é µÎ°³ ½Å°æ, ¾È¸é ½Å°æ
  • facial depth
    ¾È¸é ½Éµµ
  • facial diploic vein
    ¾ó±¼ÆÇ »çÀÌ Á¤¸Æ, ¾È¸éÆÇ°£ Á¤¸Æ
  • facial eminence
    ¾È¸é ½Å°æ ±¸
  • facial form
    ¾È¸ð
  • facial hair movement
    ¾È¸ð ¿îµ¿
  • facial hemiplegia
    ¾È¸é Æí¸¶ºñ
  • facial line
    ¾È¸é ÁÖ¸§, ¾È¸é±¸
  • facial moulage
    ¾È¸é À½Çü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
meningeal neoplasms Neoplasms located in any of the meninges, the dura mater, pia mater, or arachnoid.
(12 Dec 1998)
choroid neoplasms Tumours of the choroid; most common intraocular tumours are malignant melanomas of the choroid. These usually occur after puberty and increase in incidence with advancing age. Most malignant melanomas of the uveal tract develop from benign melanomas (nevi).
(12 Dec 1998)
choroid plexus neoplasms Neoplasms of the choroid plexus, blood vessels of the pia mater that project into the brain ventricles.
(12 Dec 1998)
colourectal neoplasms Cancer of the colon and rectum. The most frequent malignant tumour in the united states. Aetiological factors which increase the risk of colourectal cancer include chronic ulcerative colitis, familial polyposis of the colon, exposure to asbestos, irradiation of the cervix.
(12 Dec 1998)
colourectal neoplasms, hereditary nonpolyposis A syndrome characterised by autosomal dominant inheritance, a low mean age (41 years) for occurrence of colon cancer, and a marked increase in the proportion of tumours in the proximal colon.
(12 Dec 1998)
common bile duct neoplasms Neoplasms of the common bile duct including vater's ampulla and oddi's sphincter.
(12 Dec 1998)
pleural neoplasms Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.
(12 Dec 1998)
muscle neoplasms Neoplasms located in muscle tissue or specific muscles. They are differentiated from neoplasms, muscle tissue which are neoplasms composed of skeletal, cardiac, or smooth muscle tissue, such as myosarcoma or leiomyoma.
(12 Dec 1998)
cranial nerve neoplasms Neoplasms of any of the cranial nerves.
(12 Dec 1998)
haematologic neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of leukaemia, of lymphoma, and of the progressive, life-threatening forms of the myelodysplastic syndromes.
(12 Dec 1998)
head and neck neoplasms Neoplasms of the head and neck.
(12 Dec 1998)
skull base neoplasms Neoplasms of the base of the skull specifically, differentiated from neoplasms of unspecified sites or bones of the skull (skull neoplasms).
(12 Dec 1998)
skull neoplasms Neoplasms of the bony part of the skull.
(12 Dec 1998)
hypothalamic neoplasms Neoplasms located in the hypothalamus including the anterior, medial, and posterior portions.
(12 Dec 1998)
soft tissue neoplasms Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á